indazoles has been researched along with Angiomatosis Retinae in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bannykh, S; Fan, X; Hu, J; Nelson, T; Rudnick, J; Vail, E | 1 |
| Asthagiri, AR; Chen, CJ; Ilyas, A; Mehta, GU; Oldfield, EH; Schiff, D; Taylor, DG | 1 |
| Ahrar, K; Fuller, GN; Gombos, DS; Jonasch, E; Liu, D; Matin, SF; McCutcheon, IE; Perrier, ND; Pilie, PG; Robichaux, CC; Villarreal, MF; Waguespack, SG; Weldon, JA; Woodson, AH | 1 |
| Giles, RH; Gläsker, S | 1 |
| Dietrich, PY; Haller, S; Koka, A; Leemann, B; Merkler, D; Migliorini, D; Pugliesi-Rinaldi, A; Schaller, K | 1 |
| Bhalla, IP; Bukowski, RM; Choueiri, TK; Elson, P; Ganapathi, R; Golshayan, AR; Jaeger, E; Rini, BI; Sein, N; Sercia, L; Simko, J; Small, EJ; Vaziri, SA; Waldman, FM; Weinberg, V; Wood, L; Zhou, M | 1 |
| Jonasch, E; Kim, BY; McCutcheon, IE | 1 |
| Chew, K; Fong, K; Jaeger, E; Rini, BI; Sein, N; Simko, J; Small, EJ; Waldman, FM; Weinberg, V | 1 |
1 review(s) available for indazoles and Angiomatosis Retinae
| Article | Year |
|---|---|
Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Topics: Adult; Angiogenesis Inhibitors; Brain Neoplasms; Cervical Vertebrae; Female; Follow-Up Studies; Hemangioblastoma; Humans; Indazoles; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2015 |
1 trial(s) available for indazoles and Angiomatosis Retinae
| Article | Year |
|---|---|
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.
Topics: Adult; Angiogenesis Inhibitors; Female; Humans; Indazoles; Male; Prospective Studies; Pyrimidines; Sulfonamides; Texas; Time Factors; Treatment Outcome; von Hippel-Lindau Disease | 2018 |
6 other study(ies) available for indazoles and Angiomatosis Retinae
| Article | Year |
|---|---|
Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Ear Neoplasms; Endolymphatic Sac; Humans; Indazoles; Male; Prognosis; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2020 |
Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Topics: Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Central Nervous System Neoplasms; Hemangioblastoma; Humans; Indazoles; Kidney Neoplasms; Male; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2018 |
The first prospective trial for von Hippel-Lindau disease: pazopanib.
Topics: Humans; Indazoles; Prospective Studies; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2018 |
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Axitinib; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Chi-Square Distribution; DNA Primers; Female; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Logistic Models; Male; Middle Aged; Mutation; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Sorafenib; Sunitinib; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2008 |
Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.
Topics: Cerebellar Neoplasms; Hemangioblastoma; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Sulfonamides; Treatment Outcome; von Hippel-Lindau Disease | 2012 |
Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Bevacizumab; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Mutation; Pyrroles; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2006 |